Ligands of peroxisome proliferator-activated receptor gamma inhibit lung cancer cell growth and induce apoptosis by stimulation of P21 expression.
Han
Shouwei
S
Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA. shan2@emory.edu
Sidell
Neil
N
Fisher
Paul B
PB
Roman
Jesse
J
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017209:Apoptosis; D002839:Chromans / Q000627:therapeutic use*; D019938:Cyclin D1 / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D015230:Prostaglandin D2 / Q000031:analogs & derivatives / Q000627:therapeutic use*; D016283:Proto-Oncogene Proteins p21(ras) / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism; D045162:Thiazolidinediones / Q000627:therapeutic use*; D014157:Transcription Factors / Q000378:metabolism; D000077288:Troglitazone
C477819:15-deoxyprostaglandin J2; D000970:Antineoplastic Agents; D002839:Chromans; D012333:RNA, Messenger; D018160:Receptors, Cytoplasmic and Nuclear; D045162:Thiazolidinediones; D014157:Transcription Factors; D019938:Cyclin D1; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras); D000077288:Troglitazone; D015230:Prostaglandin D2; C039671:ciglitazone